Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia. Rosenson RS, Gaudet D, Hegele RA, Ballantyne CM, et al. N Engl J Med 2024 May 29. doi: 10.1056/NEJMoa2404147.

Read + Share

Amedeo Smart

Independent Medical Education

Rosenson RS, Gaudet D, Hegele RA, Ballantyne CM, et al. Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia. N Engl J Med 2024 May 29. doi: 10.1056/NEJMoa2404147.
PMID: 38809174